Expression of the low-density lipoprotein receptor, HMG-CoA reductase, and multidrug resistance (Mdr1) genes in colorectal carcinomas.

[1]  S. Vitols,et al.  Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia , 1995, Medical oncology.

[2]  G. Juliusson,et al.  Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy- 3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells , 1994 .

[3]  G. Giaccone,et al.  Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  W. Scheithauer,et al.  MDR1 gene expression in primary colorectal carcinomas. , 1993, British Journal of Cancer.

[5]  O. Larsson,et al.  Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. , 1992, Cancer research.

[6]  R. Zittoun,et al.  Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. , 1992, Leukemia.

[7]  H. Luthman,et al.  Quantitative determination of mdrl gene expression in leukaemic cells from patients with acute leukaemia , 2007 .

[8]  S. Bates,et al.  Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines. , 1992, Journal of the National Cancer Institute.

[9]  C. Seynaeve,et al.  A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance. , 1991, British Journal of Cancer.

[10]  G. Margison,et al.  Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. , 1991, Cancer research.

[11]  T. Tsuruo,et al.  Expression of the MDR1 gene in human gastric and colorectal carcinomas. , 1990, Journal of the National Cancer Institute.

[12]  S. Vitols,et al.  Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex. , 1990, British Journal of Cancer.

[13]  K. Einarsson,et al.  Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Gahrton,et al.  Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  V. Ling,et al.  P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines. , 1989, Cancer research.

[16]  I. Pastan,et al.  Expression of Multidrug Resistance Gene in Human Cancers , 1989 .

[17]  M. Nakanishi,et al.  Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. , 1988, The Journal of biological chemistry.

[18]  I. Pastan,et al.  The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. , 1987, The Journal of biological chemistry.

[19]  I. Pastan,et al.  Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene , 1986, Molecular and cellular biology.

[20]  D. Housman,et al.  Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.

[21]  I. Pastan,et al.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. , 1986, Science.

[22]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[23]  G. Gahrton,et al.  HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIA , 1985, The Lancet.

[24]  G. Canti,et al.  In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice. , 1984, Cancer letters.

[25]  C. McArdle,et al.  Low-density lipoprotein metabolism in mice with soft tissue tumours. , 1984, Biochimica et biophysica acta.

[26]  R. Palmiter,et al.  A practical approach for quantitating specific mRNAs by solution hybridization. , 1983, Analytical biochemistry.

[27]  P. Tartter,et al.  Serum cholesterol and human colon cancer. , 1981, Journal of the National Cancer Institute.

[28]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[29]  M. Brown,et al.  Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. , 1978, Blood.

[30]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[31]  B. Efron,et al.  The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy , 1975, Cancer.

[32]  E. Bjelke.  COLON CANCER AND BLOOD-CHOLESTEROL , 1974 .

[33]  M. Lockshin,et al.  Letter: Lymphocyte response. , 1974, Lancet.

[34]  W. Kannel,et al.  Colon cancer and blood-cholesterol. , 1974, Lancet.

[35]  K. Danø.  Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. , 1973, Biochimica et biophysica acta.

[36]  I. Pastan,et al.  Expression of the Multidrug Resistance Gene in Human Cancer , 1991 .

[37]  I. Pastan,et al.  Expression of a multidrug-resistance gene in human tumors and tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  V. Ling,et al.  Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies , 1985, Nature.

[39]  C. Lamers,et al.  Letter: Streptozotocin in the Zollinger-Ellison syndrome. , 1975, Lancet.